Menopause Starts Earlier Than You Think

Dr. Shweta Patel, MD, FACOG

Board-certified OB/GYN • U.S. Navy veteran (13 years) • Author, The Book of Hormones • Founder, Gaya Wellness

Published March 5, 2025 • Updated May 3, 2026

Let me be clear: this is not a scare article telling every woman in her 20s that menopause is around the corner. That is lazy medicine and bad messaging. Most women in their 20s are not near menopause. Many will have years of normal ovulation, predictable cycles, and healthy fertility ahead of them.

But it is also not true that the ovaries stay unchanged until age 45 and then suddenly collapse. Ovarian aging is a gradual biologic process. It affects egg number, egg quality, hormone signaling, cycle patterns, fertility timing, bone health, cardiovascular risk, sleep, mood, and sexual health. The part women are rarely told is that the ovarian clock and the birthday clock do not always move together.

Here is what I see in my practice: women who were told for years that absent periods were “normal for you,” that night sweats were anxiety, that painful sex was relationship stress, or that low AMH “doesn’t matter unless you’re infertile.” Then, when they finally want a baby or cannot function because their hormones are crashing, everyone acts surprised.

That is the system failure. We do not need to frighten young women. We need to stop infantilizing them. Women deserve an honest explanation of ovarian aging, primary ovarian insufficiency, perimenopause, fertility preservation, and the symptoms that deserve evaluation before the window gets smaller.

Ovarian Aging Is Not Menopause

Menopause is defined after 12 months without a period because ovarian hormone production has permanently declined. In the United States, the average age is around 51 to 52. Perimenopause is the transition leading up to that final period, usually beginning in the 40s, though timing varies.

Ovarian aging starts much earlier. You are born with a finite number of oocytes. Over time, that pool declines. Egg quality also changes with age, largely because chromosomes are more likely to divide abnormally. This is why fertility may look effortless at 27, feel uncertain at 36, and become medically complex at 42 even when periods are still coming.

The 2025 ACOG Committee Statement on ovarian-factor fertility decline updates the older age-related fertility decline guidance and emphasizes anticipatory counseling, not panic. That distinction matters. Counseling means helping women understand timing, risks, family-building options, and factors that can accelerate ovarian reserve loss. Panic means throwing fear at women without a plan.

AMH, or anti-Mullerian hormone, is often marketed as an “egg count” test. It is not that simple. ACOG’s guidance on AMH in women not seeking fertility care warns against using one AMH result to predict natural fertility. AMH can help estimate ovarian response in fertility treatment, but it cannot tell you with certainty whether you can get pregnant this month or how long you have.

That is the nuance women are missing. Low AMH is not a prophecy. Regular periods are not a guarantee. Ovarian aging is real, but it has to be interpreted in context: age, cycle pattern, symptoms, family history, medical history, endometriosis, ovarian surgery, chemotherapy, autoimmune disease, smoking, and reproductive goals.

POI Is Not the Same Thing as Perimenopause

Primary ovarian insufficiency, or POI, means loss of ovarian activity before age 40. It is not just “early perimenopause.” It can involve irregular or absent cycles, elevated FSH, low estradiol, vasomotor symptoms, infertility, and long-term risks to bone and cardiovascular health if estrogen deficiency is not addressed.

The 2024 international POI guideline, published through ESHRE and ASRM, defines POI as disordered menstrual cycles for at least 4 months with an elevated FSH over 25 IU/L before age 40. The updated guideline notes that one elevated FSH can establish the diagnosis when the clinical picture fits, while repeat FSH or AMH may be useful when the diagnosis is uncertain. That is a major shift from older approaches that waited for two abnormal tests and sometimes lost time.

Perimenopause is different. It is the normal menopause transition, usually later, with fluctuating ovarian function. STRAW+10 staging describes early menopausal transition by persistent menstrual cycle variability of 7 days or more, and later transition by skipped cycles of 60 days or more. The Menopause Society’s patient guidance on perimenopause explains that changing flow and frequency happen because ovulation becomes less predictable.

A 28-year-old with 5 months of absent periods, hot flashes, and high FSH should not be told, “Maybe you’re just stressed.” A 44-year-old whose cycles vary by 10 days and who has new night sweats may be in perimenopause. Both deserve care. They do not need the same diagnosis or the same plan.

Cycle Changes That Deserve Attention

A menstrual cycle is a vital sign. It is not perfect, but it is information. When a clinician dismisses a major cycle change without asking why, they are ignoring one of the clearest endocrine signals the body gives.

Some changes can be normal: an occasional late period, a cycle that shifts during travel, a missed period after major illness, or temporary disruption from weight change, overtraining, medication, breastfeeding, or acute stress. But repeated changes deserve evaluation. That includes cycles consistently shorter than 21 days, longer than 35 to 40 days, new spotting, heavy bleeding, 3 months without a period, or a pattern that is clearly different from your baseline.

In your 20s and 30s, common causes include pregnancy, thyroid disease, high prolactin, PCOS, hypothalamic amenorrhea from underfueling or overtraining, medications, endometriosis, structural bleeding causes, and sometimes POI. If you are in your 40s, perimenopause becomes more likely, but abnormal bleeding still needs a safety lens.

At Gaya, I do not treat cycle changes as a nuisance. They are part of a bigger pattern that may include hormonal imbalance, PCOS, thyroid changes, metabolic dysfunction, sleep disruption, sexual pain, or endometriosis. The goal is not to label every woman with a disease. The goal is to stop missing the woman who actually has one.

The Symptoms Clinicians Miss

Dismissive care misses early endocrine signals because it treats symptoms as separate complaints. A woman says her periods disappeared, her sleep changed, sex hurts, she is suddenly hot at night, and her mood feels unfamiliar. The rushed answer is: stress, birth control, antidepressant, come back later.

Sometimes stress is involved. But stress is not a complete diagnosis. Symptoms that deserve evaluation include absent periods, repeated skipped cycles, hot flashes, night sweats, new vaginal dryness, painful sex, lower libido with other hormone changes, infertility, recurrent pregnancy loss, hair loss, milky nipple discharge, new acne or facial hair, pelvic pain, heavy bleeding, and symptoms after chemotherapy, pelvic radiation, ovarian surgery, or autoimmune disease.

ACOG’s guidance on primary ovarian insufficiency in adolescents and young women notes that the most common presenting symptom is primary or secondary amenorrhea, and initial evaluation should include FSH, estradiol, pregnancy testing, thyroid testing, and prolactin testing. That is not exotic medicine. That is basic pattern recognition.

If POI is confirmed, the next conversation is not only fertility. It is also estrogen replacement until the usual age of menopause when not contraindicated, bone health, cardiovascular risk, emotional impact, contraception if pregnancy is not desired, and referral when fertility preservation or assisted reproduction is part of the plan. Women should not have to discover all of that from a search bar after being brushed off in an exam room.

Fertility Preservation Is Not a Fear Tactic

Egg freezing is not an obligation. It is also not a vanity procedure. It is a medical option that may be worth discussing when timing, risk, and values line up. The ethical problem is not that women are offered fertility preservation. The ethical problem is when they are either sold certainty or denied information.

ASRM’s 2024 Ethics Committee opinion on planned oocyte cryopreservation emphasizes that success depends heavily on age at freezing, ovarian reserve, and the number of mature oocytes banked. Translation: freezing eggs at 29 is not the same probability conversation as freezing at 39. Cost, access, injections, retrieval risk, storage fees, future IVF, and the possibility of no live birth all need to be discussed honestly.

Women with medical risk need a different urgency level. Fertility preservation should be discussed before chemotherapy, pelvic radiation, some ovarian surgeries, gender-affirming gonadectomy, or treatment for conditions that may damage ovarian reserve. Women with a strong family history of early menopause, known genetic risk, severe endometriosis, prior ovarian surgery, or unexpectedly low ovarian reserve for age may also benefit from a reproductive endocrinology consult.

This is where gynecology and fertility medicine should work together. Your OB/GYN should recognize the signal, start the right evaluation, and refer when fertility preservation is time-sensitive. Your fertility specialist should explain realistic odds. Nobody should be selling fear. Nobody should be selling denial.

What a Better Workup Looks Like

A better workup starts with your story: age, cycle history, last normal period, pregnancy possibility, contraception, birth control use, postpartum status, exercise, nutrition, weight change, stress load, medications, hot flashes, night sweats, vaginal symptoms, pelvic pain, acne, hair growth, headaches, nipple discharge, autoimmune history, chemo or radiation exposure, ovarian surgery, family history of early menopause, and pregnancy goals.

Testing should be targeted. Depending on the situation, that may include pregnancy test, TSH, prolactin, FSH, estradiol, AMH, androgen testing, pelvic ultrasound, CBC, iron studies, metabolic markers, and screening for autoimmune or genetic causes when POI is suspected. If bleeding is heavy or abnormal, the bleeding pathway matters too.

Inside Hormonal Agency, I do not separate hormones from the rest of the body. We look at cycle signals, perimenopause, menopause, sexual health, sleep, mood, weight changes, and risk profile together. That is how endocrine care should work.

For some women, the plan is reassurance with follow-up. For others, it is POI evaluation, hormone therapy, contraception that does not mask the whole picture, referral to reproductive endocrinology, pelvic imaging, thyroid treatment, nutrition support, or a broader metabolic plan. Precision is kinder than vague reassurance.

The Bottom Line

Women in their 20s do not need to be scared into thinking menopause is imminent. They do need to know that ovarian aging is real, that fertility decline is not a moral failure, and that early endocrine symptoms deserve attention. POI is rare, but it is life-changing when missed. Perimenopause is common, but it should not be used as a lazy explanation for every symptom. Low AMH is not destiny, but it is not meaningless in the right context.

If you are reading this and recognizing your own story, do not panic. Get specific. Track your cycles. Write down symptoms. Ask what diagnosis is being considered. Ask what has been ruled out. Ask whether your fertility goals change the urgency. Ask whether the plan protects your bones, heart, uterus, sleep, sex life, and future options.

Your body changed – your approach needs to change with it. That does not mean you are broken. It means you need a clinician who can hear an early signal before it becomes a crisis.

Dr. Shweta Patel, MD, FACOG

Board-certified OB/GYN, U.S. Navy veteran, and founder of Gaya Wellness. Dr. Patel leads physician-managed programs in hormone optimization, hormone replacement therapy for women, and longevity medicine for women who are tired of being dismissed.

You have not failed. Your plan did.